Michelle L. Badura
0000-0001-5325-8097
Publication & Citation Trends
Most Cited Works
Publications
131 total
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer PDF
Cited by 36
OpenAlex
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors PDF
Cited by 17
OpenAlex
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer PDF
Cited by 10
OpenAlex
Large tandem duplications in cancer result from transcription and DNA replication collisions PDF
Cited by 4
OpenAlex
Abstract 299: Large tandem duplications in cancer resulting from transcription and DNA replication collisions
Cited by 0
Semantic Scholar
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells PDF
Cited by 83
OpenAlex
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer PDF
Cited by 55
OpenAlex
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin PDF
Cited by 154
OpenAlex
Research Topics
Lung Cancer Research Studies
(56)
Neuroendocrine Tumor Research Advances
(43)
Peptidase Inhibition and Analysis
(41)
Prostate Cancer Treatment and Research
(40)
Immunotherapy and Immune Responses
(29)
Frequent Co-Authors
Affiliations
Santa Clara University
University of California, San Francisco
Columbia University Irving Medical Center
Health First
Czech Academy of Sciences, Institute of Microbiology